N. Tzarum

Scripps Research Institute — United States

Medicine · Health Sciences

19h-index1.5kcitations50works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(18), Hepatitis C virus research(17), Monoclonal and Polyclonal Antibodies Research(16), Hepatitis B Virus Studies(10), Immune Response and Inflammation(9)

Publications49 total

Structural and genetic signatures of two classes of HCV E2 neutralizing face antibodies from non-human primates immunized with a recombinant E1E2
2025Open Access
Author Correction: Systematic discovery of antibacterial and antifungal bacterial toxins
Nature Microbiology·2025Open Access
Systematic discovery of antibacterial and antifungal bacterial toxins
Nature Microbiology·2024· 11 cited
What has been will be again—The story of viral pathogens
Cell Host & Microbe·2022
Systematic Discovery of Antibacterial and Antifungal Bacterial Toxins
2021· 3 citedOpen Access
From Structural Studies to HCV Vaccine Design
Viruses·2021· 20 citedOpen Access
Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins
Immunity·2021· 39 citedOpen Access
Lessons from applied large-scale pooling of 133,816 SARS-CoV-2 RT-PCR tests
Science Translational Medicine·2021· 100 citedOpen Access
An alternate conformation of HCV E2 neutralizing face as an additional vaccine target
Science Advances·2020· 42 citedOpen Access
Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection
Clinical Microbiology and Infection·2020· 210 citedOpen Access
Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody U1
2020
Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines
Science Advances·2020· 67 citedOpen Access
Structure of Hepatitis C Virus Envelope Glycoprotein E2c3 core from genotype 6a bound to broadly neutralizing antibody AR3A and non neutralizing antibody E1
2019
Rational design of hepatitis C virus E2 core nanoparticle vaccines
2019Open Access
N-Glycolylneuraminic Acid as a Receptor for Influenza A Viruses
Cell Reports·2019· 105 citedOpen Access
VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design
Current Opinion in Virology·2019· 130 citedOpen Access
Genetic and structural insights into broad neutralization of hepatitis C virus by human V <sub>H</sub> 1-69 antibodies
Science Advances·2019· 97 citedOpen Access
Crystal structure of H5 hemagglutinin mutant Y161A from A/Viet Nam/1203/2004 H5N1 influenza virus in complex with 3'-GcLN
2018
Crystal structure of H5 hemagglutinin mutant Y161A from A/Viet Nam/1203/2004 H5N1 influenza virus
2018
Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors
Proceedings of the National Academy of Sciences·2018· 17 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Ian A. Wilson(30), Mansun Law(16), Erick Giang(9), Oded Livnah(9), Xueyong Zhu(5), Wenli Yu(5), Robert P. de Vries(5), Jiang Zhu(5), Kenna Nagy(5), Ryan McBride(5), James C. Paulson(5), Xinping Zhu(5), Leopold Kong(4), Linling He(4), Y. Eisenberg-Domovich(4), Agnes Klochendler(3), Tal Sido(3), Monique H. Verheije(3), Jannick Prentoe(3), Elias H. Augestad(3)